2021 Q4 Form 10-Q Financial Statement

#000093976721000097 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $328.4M $385.2M $231.1M
YoY Change 42.12% 48.44% -3.83%
Cost Of Revenue $11.87M $14.88M $8.725M
YoY Change 36.09% 61.41% -16.9%
Gross Profit $316.5M $370.3M $159.9M
YoY Change 98.01% 118.45% -30.43%
Gross Profit Margin 96.38% 96.14% 69.18%
Selling, General & Admin $101.6M $98.50M $88.19M
YoY Change 15.16% 64.73% 52.04%
% of Gross Profit 32.08% 26.6% 55.16%
Research & Development $163.4M $148.8M $176.8M
YoY Change -7.58% 29.46% 87.25%
% of Gross Profit 51.61% 40.18% 110.57%
Depreciation & Amortization $1.931M $4.804M $2.400M
YoY Change -19.54% 108.87% 9.09%
% of Gross Profit 0.61% 1.3% 1.5%
Operating Expenses $264.9M $247.3M $264.9M
YoY Change -0.01% 41.53% 73.74%
Operating Profit $51.62M $123.0M -$42.58M
YoY Change -221.23% 62.85% -155.08%
Interest Expense $1.441M $1.658M $3.500M
YoY Change -58.83% -58.55% -54.55%
% of Operating Profit 2.79% 1.35%
Other Income/Expense, Net -$19.00K -$11.00K $565.0K
YoY Change -103.36%
Pretax Income $118.0M $124.9M -$38.02M
YoY Change -410.41% 54.76% -144.73%
Income Tax $15.06M $28.80M -$5.981M
% Of Pretax Income 12.76% 23.06%
Net Earnings $38.20M $96.09M -$32.04M
YoY Change -219.24% 43.81% -146.64%
Net Earnings / Revenue 11.63% 24.95% -13.86%
Basic Earnings Per Share $0.12 $0.31 -$0.10
Diluted Earnings Per Share $0.12 $0.30 -$0.10
COMMON SHARES
Basic Shares Outstanding 315.4M shares 314.1M shares 309.1M shares
Diluted Shares Outstanding 322.0M shares 322.9M shares 309.1M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.467B $1.403B $1.207B
YoY Change 21.6% 18.08% 41.57%
Cash & Equivalents $647.2M $492.5M $334.0M
Short-Term Investments $819.9M $835.4M $887.3M
Other Short-Term Assets $57.53M $51.56M $57.00M
YoY Change 0.93% 71.88% 111.11%
Inventory $27.49M $24.98M $19.32M
Prepaid Expenses
Receivables $282.7M $179.5M $160.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.835B $1.593B $1.408B
YoY Change 30.33% 14.24% 39.22%
LONG-TERM ASSETS
Property, Plant & Equipment $104.0M $95.13M $56.39M
YoY Change 84.5% 81.82% 15.31%
Goodwill $63.68M $63.68M $63.68M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $371.1M $331.1M $332.3M
YoY Change 11.68% -7.11% -38.05%
Other Assets $131.0M $134.9M $69.41M
YoY Change 88.74% 123.01% -69.22%
Total Long-Term Assets $781.5M $774.0M $703.2M
YoY Change 11.13% 18.74% -19.58%
TOTAL ASSETS
Total Short-Term Assets $1.835B $1.593B $1.408B
Total Long-Term Assets $781.5M $774.0M $703.2M
Total Assets $2.616B $2.367B $2.111B
YoY Change 23.93% 15.67% 11.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.26M $20.45M $47.93M
YoY Change -49.39% 124.65% 313.16%
Accrued Expenses $226.3M $159.3M $115.9M
YoY Change 95.23% 60.94% 27.78%
Deferred Revenue $7.814M $6.314M $1.300M
YoY Change 501.08% 385.69%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $337.6M $255.3M $201.3M
YoY Change 67.67% 78.95% 41.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.023M $7.068M $721.0K
YoY Change 1012.76% -1.92% -98.74%
Total Long-Term Liabilities $8.023M $7.068M $721.0K
YoY Change 1012.76% -1.92% -98.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $337.6M $255.3M $201.3M
Total Long-Term Liabilities $8.023M $7.068M $721.0K
Total Liabilities $405.6M $324.2M $259.0M
YoY Change 56.6% 52.04% 29.7%
SHAREHOLDERS EQUITY
Retained Earnings -$216.5M -$349.9M -$476.0M
YoY Change -54.51% -21.18%
Common Stock $319.0K $315.0K $309.0K
YoY Change 3.24% 1.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.211B $2.043B $1.852B
YoY Change
Total Liabilities & Shareholders Equity $2.616B $2.367B $2.111B
YoY Change 23.93% 15.67% 11.95%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $38.20M $96.09M -$32.04M
YoY Change -219.24% 43.81% -146.64%
Depreciation, Depletion And Amortization $1.931M $4.804M $2.400M
YoY Change -19.54% 108.87% 9.09%
Cash From Operating Activities $96.45M $83.31M $33.30M
YoY Change 189.65% 365.4% -78.94%
INVESTING ACTIVITIES
Capital Expenditures -$15.96M -$14.50M -$14.20M
YoY Change 12.39% 133.82% 97.22%
Acquisitions
YoY Change
Other Investing Activities $2.905M -$6.742M -$15.20M
YoY Change -119.11% -96.65% -87.63%
Cash From Investing Activities -$13.06M -$21.24M -$29.50M
YoY Change -55.75% -89.77% -77.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.99M -2.881M -18.70M
YoY Change -3.78% -15.26% 523.33%
NET CHANGE
Cash From Operating Activities 96.45M 83.31M 33.30M
Cash From Investing Activities -13.06M -21.24M -29.50M
Cash From Financing Activities -17.99M -2.881M -18.70M
Net Change In Cash 65.40M 59.19M -14.90M
YoY Change -538.95% -130.65% -159.84%
FREE CASH FLOW
Cash From Operating Activities $96.45M $83.31M $33.30M
Capital Expenditures -$15.96M -$14.50M -$14.20M
Free Cash Flow $112.4M $97.80M $47.50M
YoY Change 136.66% 305.83% -71.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000939767
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-10-01
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30235
dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3257395
dei Entity Address Address Line1
EntityAddressAddressLine1
1851 Harbor Bay Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Alameda,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94502
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
837-7000
dei Security12b Title
Security12bTitle
Common Stock $.001 Par Value per Share
dei Trading Symbol
TradingSymbol
EXEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
316397360 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
567325000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319217000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
835406000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
887319000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
179493000 USD
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
160875000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
28240000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
20973000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51564000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
57011000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1662028000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1445395000 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
362218000 USD
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
330751000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
99838000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67384000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
125295000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
156711000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
63684000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
134678000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73408000 USD
CY2021Q4 us-gaap Assets
Assets
2447741000 USD
CY2021Q1 us-gaap Assets
Assets
2137333000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24314000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23632000 USD
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
53306000 USD
CY2021Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
51189000 USD
CY2021Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
70618000 USD
CY2021Q1 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
52251000 USD
CY2021Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
31120000 USD
CY2021Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
20683000 USD
CY2021Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
35403000 USD
CY2021Q1 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
12456000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54747000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44447000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
269508000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
204658000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9444000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3755000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52252000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49086000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4090000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
721000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
335294000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
258220000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316305000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
316305000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
311627000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
311627000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
316000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
312000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1481000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2422323000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2321895000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4476000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-311673000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447570000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2112447000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1879113000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2447741000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2137333000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231092000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717486000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11874000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8725000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39956000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27235000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163370000 USD
CY2020Q4 us-gaap Interest Income Other
InterestIncomeOther
3994000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176762000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
471448000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393572000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101558000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88185000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
302404000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
210916000 USD
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
276802000 USD
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
273672000 USD
us-gaap Costs And Expenses
CostsAndExpenses
813808000 USD
us-gaap Costs And Expenses
CostsAndExpenses
631723000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
51621000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-42580000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
170022000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
85763000 USD
CY2021Q4 us-gaap Interest Income Other
InterestIncomeOther
1658000 USD
us-gaap Interest Income Other
InterestIncomeOther
6231000 USD
us-gaap Interest Income Other
InterestIncomeOther
16376000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
565000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
571000 USD
CY2021Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
53260000 USD
CY2020Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-38021000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
176133000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
102710000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15056000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5981000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40236000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19317000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
315380000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309116000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313990000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307437000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322022000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309116000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322084000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
317495000 shares
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-193000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
453000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-949000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-893000 USD
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-504000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1601000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2995000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3170000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37700000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33641000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132902000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
86563000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2043077000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-504000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3305000 USD
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5958000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34323000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316305000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2112447000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1833324000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1601000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1872000 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5179000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55655000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1852031000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1879113000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2995000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18792000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
15371000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97011000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316305000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2112447000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1685970000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3170000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19827000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26120000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85791000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1852031000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11699000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6731000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
96654000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
85791000 USD
exel Noncash Lease Expense
NoncashLeaseExpense
3952000 USD
exel Noncash Lease Expense
NoncashLeaseExpense
3607000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-32365000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-15803000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-35871000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1609000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20124000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47074000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26956000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13466000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24252000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15868000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11434000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4012000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
47812000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51151000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
304352000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
175689000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48265000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16055000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1077377000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
866975000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1095813000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
781324000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29829000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101706000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18242000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
19682000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15049000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26120000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3193000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6438000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
277716000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67545000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320772000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268137000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
598488000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335682000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
4893000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
1824000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5143000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
843000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
9000000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Fiscal Period
FiscalPeriod
<span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a 52- or 53-week fiscal year policy that generally ends on the Friday closest to December 31</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span>. Fiscal year 2021, which is a 52-week fiscal year, will end on December 31, 2021 and fiscal year 2020, which was a 52-week fiscal year, ended on January 1, 2021. For convenience, references in this report as of and for the fiscal periods ended July 2, 2021 and July 3, 2020, October 1, 2021 and October 2, 2020, and as of and for the fiscal year ended January 1, 2021, are indicated as being as of and for the fiscal periods ended June 30, 2021 and June 30, 2020, September 30, 2021 and September 30, 2020, and the year ended December 31, 2020, respectively.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying Condensed Consolidated Financial Statements conforms to accounting principles generally accepted in the U.S., which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate our significant estimates. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationsCertain prior period amounts in the accompanying Condensed Consolidated Financial Statements have been reclassified to conform to the current period presentation. Such reclassifications did not impact previously reported total revenues, income (loss) from operations, net income (loss), total assets, total liabilities or total stockholders’ equity.
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231092000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717486000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231092000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717486000 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
30536000 USD
exel Valuation Allowances And Reserves Additions For Sales In Current Period
ValuationAllowancesAndReservesAdditionsForSalesInCurrentPeriod
275879000 USD
exel Valuation Allowances And Reserves Additions For Sales In Prior Period
ValuationAllowancesAndReservesAdditionsForSalesInPriorPeriod
1415000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
260212000 USD
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
47618000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7535000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1790000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9444000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3755000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16979000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5545000 USD
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
6800000 USD
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
6800000 USD
CY2021Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
48400000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
116200000 USD
CY2020Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
33100000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
115300000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
86500000 USD
exel Collaborative Arrangement Rights And Obligations Upfront Payment
CollaborativeArrangementRightsAndObligationsUpfrontPayment
28000000 USD
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Development Milestone Payments
CollaborativeArrangementRightsAndObligationsMaximumAggregateDevelopmentMilestonePayments
98000000 USD
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Regulatory Milestone Payments
CollaborativeArrangementRightsAndObligationsMaximumAggregateRegulatoryMilestonePayments
229000000 USD
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Commerical Milestone Payments
CollaborativeArrangementRightsAndObligationsMaximumAggregateCommericalMilestonePayments
802500000 USD
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Exclusivity Payments
CollaborativeArrangementRightsAndObligationsMaximumAggregateExclusivityPayments
15000000 USD
exel Collaborative Arrangement Rights And Obligations Number Of Additional Oncology Targets
CollaborativeArrangementRightsAndObligationsNumberOfAdditionalOncologyTargets
20 target
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Research Program Funding Payments
CollaborativeArrangementRightsAndObligationsMaximumAggregateResearchProgramFundingPayments
30000000 USD
exel Collaborative Arrangement Rights And Obligations Research Program Funding Payments Term
CollaborativeArrangementRightsAndObligationsResearchProgramFundingPaymentsTerm
P3Y
exel Collaborative Arrangement Rights And Obligations Maximum Aggregate Exclusivity Payments First Installment
CollaborativeArrangementRightsAndObligationsMaximumAggregateExclusivityPaymentsFirstInstallment
5000000 USD
exel Collaborative Arrangement Rights And Obligations Aggregate Research Program Funding Payments First Installment
CollaborativeArrangementRightsAndObligationsAggregateResearchProgramFundingPaymentsFirstInstallment
2500000 USD
CY2021Q4 exel Collaborative Arrangement Rights And Obligations Option Exercise Payment
CollaborativeArrangementRightsAndObligationsOptionExercisePayment
3000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
567325000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319217000 USD
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
31163000 USD
CY2021Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1555000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
598488000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320772000 USD
CY2021Q4 us-gaap Restricted Cash Equivalents Current
RestrictedCashEquivalentsCurrent
29600000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1459665000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2102000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
127000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1461640000 USD
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1794137000 USD
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2102000 USD
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
127000 USD
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1796112000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1349982000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5931000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1355901000 USD
CY2021Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1532923000 USD
CY2021Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5931000 USD
CY2021Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000 USD
CY2021Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1538842000 USD
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
2600000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
4500000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
146326000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
127000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
56299000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
12000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
41 investment
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
14 investment
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1103122000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1034150000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
358518000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
321751000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1461640000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1355901000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10317000 USD
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
7773000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
28016000 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
20610000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11707000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7291000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
50040000 USD
CY2021Q1 us-gaap Inventory Gross
InventoryGross
35674000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
50040000 USD
CY2021Q1 us-gaap Inventory Gross
InventoryGross
35674000 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33966000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55655000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96654000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85791000 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33966000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55655000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96654000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85791000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9248609 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Stock Option Or Stock Appreciation Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToStockOptionOrStockAppreciationAward
1 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Other Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToOtherAwards
1.5 shares
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.157
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
us-gaap Net Income Loss
NetIncomeLoss
135897000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
315380000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309116000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313990000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307437000 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6642000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8094000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10058000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322022000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309116000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322084000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
317495000 shares
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26

Files In Submission

Name View Source Status
0000939767-21-000097-index-headers.html Edgar Link pending
0000939767-21-000097-index.html Edgar Link pending
0000939767-21-000097.txt Edgar Link pending
0000939767-21-000097-xbrl.zip Edgar Link pending
exel-20211001.htm Edgar Link pending
exel-20211001.xsd Edgar Link pending
exel-20211001_cal.xml Edgar Link unprocessable
exel-20211001_def.xml Edgar Link unprocessable
exel-20211001_g1.jpg Edgar Link pending
exel-20211001_htm.xml Edgar Link completed
exel-20211001_lab.xml Edgar Link unprocessable
exel-20211001_pre.xml Edgar Link unprocessable
exel20210930exhibit311.htm Edgar Link pending
exel20210930exhibit312.htm Edgar Link pending
exel20210930exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending